Neutrogena Oil-Free Acne Wash Daily Scrub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to instruct patients to cleanse their face twice daily. The cleansing process begins with wetting the face. A sufficient amount of the cleanser should be applied to the hands, followed by the addition of water to create a lather. The product should then be massaged gently onto the face to ensure effective cleansing. It is essential to rinse the face thoroughly with water to remove all traces of the cleanser.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

• Contact with the eyes should be avoided; if contact occurs, the eyes must be flushed thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to minimize adverse effects.

It is imperative to avoid contact with the eyes. Should contact occur, patients should be instructed to flush the eyes thoroughly with water to mitigate any potential irritation or damage.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is for external use only. The use of this topical acne medication may lead to skin irritation and dryness, particularly if another topical acne medication is used concurrently. In such cases, it is advised to limit the use to one topical acne medication at a time to minimize the risk of irritation.

Additionally, care should be taken to avoid contact with the eyes. Should contact occur, it is important to flush the eyes thoroughly with water to mitigate any potential adverse effects.

In the event that the product is swallowed, patients are advised to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Oil-Free Acne Wash Daily Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Neutrogena Oil-Free Acne Wash Daily Scrub in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this product in the geriatric population, as individual patient factors may influence safety and efficacy. Monitoring for any adverse reactions or sensitivities is advisable when this product is used by elderly patients.

Pregnancy

The product does not contain specific warnings or information regarding use during pregnancy. There are no explicit statements about contraindications or risks to the fetus during pregnancy provided in the prescribing information. Healthcare professionals should consider the absence of data when prescribing this product to pregnant patients and weigh the potential benefits against any unknown risks. Women of childbearing potential should be counseled regarding the lack of specific safety data during pregnancy.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals may not need to take additional precautions when prescribing this medication to lactating mothers. However, it is always advisable to monitor breastfed infants for any potential effects, as individual responses may vary.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control and emergency medical services is recommended to ensure optimal patient care and safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should instruct patients to avoid contact with the eyes. If contact occurs, patients should be advised to flush the eyes thoroughly with water to mitigate any potential irritation.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients regarding the potential for increased skin sensitivity to sunlight due to the presence of an alpha hydroxy acid (AHA) in the formulation. Patients are advised to use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week following its use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Neutrogena Oil-Free Acne Wash Daily Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)